Futura Medical Share Discussion Threads

[j777j] 12/8/2022 15:46

Not long now,news out In the next 4 weeks according to the last update.



Massive opportunity ahead.

[petroc] 12/8/2022 13:54

Keep squawking, LiarBO! We'll soon have that share price up by 10% at this rate! By the way, we're still waiting for the slightest shred of evidence that MED3000 doesn't work. You keep saying it might not but you haven't supported that with anything. Because you've got nothing. Even the FDA are convinced it works in the short term - soon it will be confirmed that it works in the long term too. Unless you have proof otherwise? No, thought not.

[j777j] 12/8/2022 13:51

Woah


325 million men



What a marketplace



2.17p wholesale x 32 million x 1x week equals

Many pounds per share!!!!

[j777j] 12/8/2022 13:50

One in five men suffers from erectile dysfunction worldwide3. Erectile dysfunction (ED) is closely linked to age and a number of co-morbidities exist such as obesity, diabetes and heart disease with the incidence of erectile dysfunction expected to increase to 322 million by 20254. Erectile dysfunction can result from organic or psychological causes and is increasingly affecting younger men who can also suffer from performance anxiety due to social pressure and false expectations from easy access to pornography. Erectile dysfunction can lead to low self-esteem, lack of confidence and depression. The detrimental impact on partners and relationships is well documented and acknowledged by the medical community. The discovery and approval of the PDE5i’s to treat ED over 20 years ago (such as Viagra® and Cialis®) not only revolutionised available treatments for men with ED but also dramatically increased awareness in the general public of this significant problem.

The number of men with ED will increase from 152 million men in 1995 to 322 million men by 20254

[lbo] 12/8/2022 13:48

Yes back in the real world. All Futura have done is also allow Reckitt to sell lubricants/arousal gels as medical device placebo treatments for ED. And report Med3000 to the ASA, FTC etc for being misleading if it doesn't inform consumers that Med3000 itself has no proven effect in ED beyond a placebo. As it has not proven efficacy in a placebo controlled study or even against any standard cooling lubricant/arousal gels.https://neo.life/2021/10/the-promise-of-pills-that-do-nothing/'You are the active ingredient'How long before Reckitt puts the final nail in the coffin?https://www.globenewswire.com/en/news-release/2022/03/17/2405009/28124/en/Global-Personal-Lubricant-Market-Outlook-Forecast-Report-2022-2027-Featuring-Prominent-Vendors-LifeStyles-Church-Dwight-Karex-Berhad-Reckitt-Benckiser-Group-BioFilm.htmlReckitt Benckiser was the defined leader and the ultimate four Personal lubricant vendors with leading brands such as Durex Play and K-Y Jelly.KEY GROWTH FACTORSIncreasing prevalence of erectile dysfunction9 Market Growth Enablers9.1 Increasing Prevalence of Erectile Dysfunctionhttps://amp.theguardian.com/business/shortcuts/2015/dec/14/how-bad-was-what-nurofen-did-austalian-courtsFor many, whether or not placebo use is ethical depends partly on whether patients are being deceived and whether there is a known better treatment.A clinician who doesn’t t deceive a patient, and who provides a placebo for something for which there is no known treatment, such as irritable bowel syndrome, might be ethically OK, says Jeremy Howick, of the Department of Primary Health Care Sciences, at the University of Oxford, and lead author of the Plos One study. â€Å"But there is no evidence that this company is enhancing care. What they’ve been doing is completely unethical

[lbo] 12/8/2022 13:44

LOL

What a ‘swindle’ the rampers are playing!




Odds estimates indicated the largest likelihood of placebo response occurred in men who were black, were younger than 45 years, had mild ED, and did not have diabetes. The likelihood of a placebo response decreased as ED duration increased.



A product that contemporary technology does not understand must establish that this ˜magic’ actually works. Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer

[petroc] 12/8/2022 13:40

Thank you LiarBO for repeating what I 've pointed out a few times - that the FDA wanted a 6 month trial instead of a 3 month trial to ensure 'the efficacy did not diminish over time'. Which just goes to prove that the FDA are already convinced that MED3000 works in the short term and want see that continue over a longer period. So here's a gun, LiarBO, there's your foot....fire!

[j777j] 12/8/2022 13:40

Buys outnumber sells 28 to 1


Short squeeze hasnt even started

[j777j] 12/8/2022 12:19

The market for erectile dysfunction


One in five men suffers from erectile dysfunction worldwide3. Erectile dysfunction (ED) is closely linked to age and a number of co-morbidities exist such as obesity, diabetes and heart disease with the incidence of erectile dysfunction expected to increase to 322 million by 20254. Erectile dysfunction can result from organic or psychological causes and is increasingly affecting younger men who can also suffer from performance anxiety due to social pressure and false expectations from easy access to pornography. Erectile dysfunction can lead to low self-esteem, lack of confidence and depression. The detrimental impact on partners and relationships is well documented and acknowledged by the medical community. The discovery and approval of the PDE5i’s to treat ED over 20 years ago (such as Viagra® and Cialis®) not only revolutionised available treatments for men with ED but also dramatically increased awareness in the general public of this significant problem.

The number of men with ED will increase from 152 million men in 1995 to 322 million men by 2025

[j777j] 12/8/2022 11:46

Being short shares that have historically multiplied in days on news,when this could be the biggest in the co's history.



Suicide Squad

[j777j] 12/8/2022 11:42

"Seeing an improvement in erectile performance and underlining the product's potential as a highly effective, safe, clinically proven, topical treatment for ED."



Short squeeze any time now

[lbo] 12/8/2022 11:32

If you believe that just an alcohol and water placebo gel will capture 10% of the global ED market then you should be buying shares in the market leader Reckitt not Futura. Who already admitted on their last failed medical device that without Reckitt



˜the immediate potential for substantial royalties is low in the absence of a large global brand 'carrier' to take the product forward’



Reckitt Benckiser was the defined leader and the ultimate four Personal lubricant vendors with leading brands such as Durex Play and K-Y Jelly.

KEY GROWTH FACTORS

Increasing prevalence of erectile dysfunction